Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
How Can Seniors Protect Themselves From Remote Monitoring Scams?
Patient Care How Can Seniors Protect Themselves From Remote Monitoring Scams?

The landscape of modern healthcare has transitioned rapidly toward home-based solutions, yet this evolution has inadvertently opened a sophisticated gateway for criminal networks to target vulnerable populations through elaborate remote monitoring schemes. Medicare fraud remains a persistent and

Is AI-Driven Virtual Care the Future of Chronic Health?
Digital Health Is AI-Driven Virtual Care the Future of Chronic Health?

As the American healthcare infrastructure grapples with a surge in patient volume, a small percentage of individuals with multiple chronic conditions continues to account for over half of all inpatient hospital admissions, creating an urgent demand for scalable solutions. Currently, approximately

Global AI Telehealth Market Set to Reach 32 Billion by 2034
Patient Care Global AI Telehealth Market Set to Reach 32 Billion by 2034

The convergence of high-speed telecommunications and sophisticated artificial intelligence is currently orchestrating a profound structural shift in how medical services are delivered and consumed across the globe. What was once a rudimentary system of video calls between physicians and patients

CMS Faces Staffing Shortages Amid Major Policy Expansions
Regulatory & Compliance CMS Faces Staffing Shortages Amid Major Policy Expansions

The vast machinery of the Centers for Medicare and Medicaid Services is currently attempting to manage the healthcare needs of more than 160 million American citizens with a workforce that has dwindled by 1,000 employees over the course of the past calendar year. This significant reduction in human

White House Budget Slashes Health Spending to Boost Defense
Regulatory & Compliance White House Budget Slashes Health Spending to Boost Defense

The latest fiscal year 2027 budget proposal released by the White House represents one of the most aggressive shifts in federal spending priorities in recent memory, targeting a double-digit reduction in domestic health services to fund a historic expansion of the national military infrastructure.

FDA Approves First Cerebral Venous Stent for IIH Treatment
Patient Care FDA Approves First Cerebral Venous Stent for IIH Treatment

Living with a constant, debilitating pressure inside the skull that mimics the symptoms of a growing brain tumor represents a terrifying reality for many individuals diagnosed with idiopathic intracranial hypertension. This neurological condition, commonly known as IIH, is characterized by an

How Will Headway’s AI Acquisition Change Mental Health Care?
Digital Health How Will Headway’s AI Acquisition Change Mental Health Care?

The persistent disconnect between clinical demand and administrative feasibility has long been a defining challenge for the mental health sector as providers struggle to balance patient care with the grueling demands of insurance compliance and documentation. While digital platforms have

How Will RCM-Native AI Change Healthcare Billing?
Digital Health How Will RCM-Native AI Change Healthcare Billing?

The American medical economy is currently witnessing a tectonic shift as the era of "good enough" automation vanishes in favor of hyper-specialized, revenue-cycle-native intelligence. For years, health systems operated within a fragile financial architecture, where the friction between clinical

How Is Medtronic Transforming Surgery With Stealth AXiS?
Regulatory & Compliance How Is Medtronic Transforming Surgery With Stealth AXiS?

Precision in the operating room has long been the holy grail of neurosurgery, yet the margin for error remains microscopic when navigating the intricate corridors of the human brain and spine. Medtronic is currently spearheading a significant shift in this landscape by targeting the $15 billion

Is NewYork-Presbyterian Violating Federal Antitrust Laws?
Regulatory & Compliance Is NewYork-Presbyterian Violating Federal Antitrust Laws?

The Legal Challenge Against Manhattan’s Healthcare Giant The legal battle currently unfolding between the United States Department of Justice and NewYork-Presbyterian serves as a high-stakes referendum on the pricing power of urban hospital conglomerates. The Justice Department launched this

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later